Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product


Product Description

Sandoz is a world leading manufacturer of biotechnological products. Our expertise stems from decades of experience in this complex field, particularly in the production of intermediates for third parties. Early successes were marked by the production of the first-ever oral penicillin in 1951 (anti-infectives), and one of the first recombinant proteins, an interferon, in 1980 (biopharmaceuticals).

Over the years, our role has evolved from simply a contract manufacturer to a full-service provider, i.e. providing solutions for all steps in the value chain of a project through to building strong relationships with our partners. Underlying this role is trust – trust in the shared values of a global company, trust in the innovative solutions we provide, and trust in the quality of our products and services on the back of our long history and industry know-how.

Sandoz has traditionally been among the leading specialists in microbial fermentation of classic and recombinant microorganisms. Our comprehensive know-how is based on several decades of experience in the fields of classical microbial products and recombinant microbial production at a commercial scale. In 2004, we successfully extended our production technology into the field of mammalian cell culture.

Today, we are a fully integrated manufacturer of recombinant products. We provide customized solutions for our partners that span the entire value chain, from development to production and fill and finish to customers. The flexibility in production capabilities to fully integrated services offers a variety of options when it comes to scaling different phases of development and commercial manufacturing, furthering the cost advantage to customers.

Sandoz is currently engaged in biotech cooperations with a number of leading organizations and continuously looks to extend its number of partnerships in the future. This strong experience combined with a successful track record of accomplishments and state-of-the-art plants, offers a unique opportunity to partners interested in pursuing manufacturing cooperations.

Product Sandoz
Company Sandoz
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Industriestrasse 25 83607 Holzkirchen Germany

Tel: +49 (0) 8024 476-0
Fax: +49 (0) 8024 476-2599

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos